How about Sinopharm Zhijun (Suzhou) Pharmaceutical Co., Ltd.?

Introduction: The company was founded in 2003. In February 2009, it was reorganized with Shenzhen Accord Pharmaceutical Co., Ltd., a subsidiary of Sinopharm Holdings, a subsidiary of China National Pharmaceutical Group, to become its holding subsidiary; in July 2012, it signed a merger agreement with Sinopharm Accord. The company entered into an equity-holding agreement and became a wholly-owned subsidiary of Sinopharm Accord. In 2013, it was officially renamed Sinopharm Zhijun (Suzhou) Pharmaceutical Co., Ltd. The registered capital is 180 million yuan, the total assets are 530 million yuan, and it covers an area of ??130,000 square meters. The company integrates R&D, production, and sales of pharmaceutical intermediates, APIs, and preparations. Its main products include cephalosporin APIs and preparations, general chemical APIs and preparations, and its products cover antibiotics, antidepressants, antiviral, antiallergic, and anti-inflammatory products. In the fields of analgesia and cardiovascular, the dosage forms include injections, tablets, capsules and granules. Products are exported to the United States, Europe, India, Pakistan, Japan, South Korea, Russia, Cyprus and other countries and regions. Zhijun (Suzhou) uses continuous technological innovation to enhance value for customers, protect human health, and aspires to become a respected brand enterprise with excellent character, noble taste, and perfect quality in the pharmaceutical industry; with "life "Guardian of Health" as our mission, adhering to the corporate spirit of "specialization, efficiency, cooperation, and win-win"; adhering to the management philosophy of "employees first, customers first, quality first, innovation for the future"; market-oriented, With the customer as the center, quality as the basis, performance as the goal, we will follow the development path of "professionalization, refinement and internationalization" and dedicate our sincerity and love to the cause of human health!

Legal representative: Li Fen

Date of establishment: 2003-03-10

Registered capital: RMB 180 million

Affiliation Region: Jiangsu Province

Unified Social Credit Code: 913205857473146062

Business status: In business

Industry: Manufacturing

Company type ：Limited liability company

English name: Sinopharm Zhijun (Suzhou) Pharmaceutical Co., Ltd.

Staff size: 500-999 people

Business address: Taicang Fuhao Economic Development Zone

Business scope: production and sales of common APIs, cephalosporin APIs and preparations (all operations approved by the "Drug Production License" and "Safety Production License" at the same time Scope of business); wholesale and retail of pharmaceutical excipients and chemical raw materials (excluding dangerous goods); export business of the company's self-produced products and technologies and import of machinery and equipment, spare parts, raw and auxiliary materials and technologies required by the company Business, except for goods and technologies that are restricted by the state or prohibited from being imported or exported.

(Projects that require approval according to law can only be carried out with approval from relevant departments)